News Roundup
- Vizient Announces 2023 Innovative Technology Exchange, Supplier Applications Now Being Accepted: The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their technologies to supply chain and clinical leaders from Vizient’s member hospitals and subject matter experts who serve on Vizient member councils. Vizient Newsroom
- Hospital Drug Spending to Increase Through July 2024: Vizient is forecasting a 3.78% rise in pharmacy prices in hospitals and non-acute care facilities, reflecting increases in prices and utilization. Formulary Watch
- Abbvie Faces Competitor as a New Humira Biosimilar Comes to Market: On January 31, 2023, AbbVie faces a new competitor as Amgen releases a Humira biosimilar onto the market in the U.S. Pharmanews Intelligence
- Vizient Shares Feedback with the National Quality Forum on Health Equity Measures: Vizient submitted comments to the National Quality Forum (NQF) regarding various health improvement measures under consideration by the Centers for Medicare & Medicaid Services. Vizient Newsroom
Blogs You May Have Missed
- The Big Picture: How Artwork Positively Impacts the Healthcare Environment
- Top Trends, Technology and Themes from the Radiology Society of North America’s Radiology Conference & Annual Meeting
- Three Years In – and the End of the PHE Declaration is in Sight